Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients

scientific article published on 24 September 2009

Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00520-009-0734-Z
P698PubMed publication ID19777270

P50authorAdele GreenQ40673023
Alexandra M. ClavarinoQ40786408
Penelope M. WebbQ41235493
David WyldQ56578616
James DoeckeQ56704968
Vanessa L BeesleyQ58753081
P2093author name stringAlessandra B Francesconi
Keith R Horwood
Colleen A Loos
P2860cites workNew guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaQ27860904
Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideationQ28307938
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviewsQ33837105
Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general publicQ35169442
Changes in preferences for life-sustaining treatment among older persons with advanced illnessQ35728623
Cancer patients' perceptions of their disease and its treatmentQ36466265
Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?Q36622427
Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directionsQ36996972
The power of compassion: truth-telling among American doctors in the care of dying patientsQ38566123
Beliefs and practices of patients with advanced cancer: implications for communicationQ38802820
Transforming the death sentence: elements of hope in women with advanced ovarian cancerQ40152778
Quality of life in cancer patients--an hypothesisQ41561511
Patient and physician preferences for surgical and adjuvant treatment options for rectal cancerQ43873517
Patterns and progress in ovarian cancer over 14 yearsQ46494571
Depression, Hopelessness, and suicidal ideation in the terminally ill.Q47349365
Information and participation preferences among cancer patientsQ47358010
Illusions in advanced cancer: the effect of belief systems and attitudes on quality of life.Q47358446
Level and direction of hope in cancer patients: an exploratory longitudinal studyQ47572084
Treatment preferences in recurrent ovarian cancer.Q53424504
Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer.Q53495072
The new medical ethics. A second opinionQ58667117
Understanding the Treatment Preferences of Seriously Ill PatientsQ59607331
Predictors of psychosocial adjustment in patients newly diagnosed with gynecological cancerQ70874850
Goals of palliative cancer therapyQ72068688
Collusion in doctor-patient communication about imminent death: an ethnographic studyQ73250724
Stage at diagnosis of ovarian cancer in the United States, 1992-1997Q73357586
Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer IntergroupQ74339084
Developmental chemotherapy and management of recurrent ovarian cancerQ80622571
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregiversQ80863074
P433issue8
P921main subjectovarian cancerQ172341
P304page(s)943-949
P577publication date2009-09-24
P1433published inSupportive Care in CancerQ15766919
P1476titleRanked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients
P478volume18